Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action

We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Dysangco, Andrew T., Pierce, Tamra M., Bravata, Dawn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726489/
https://www.ncbi.nlm.nih.gov/pubmed/36483417
http://dx.doi.org/10.1017/ash.2022.286
_version_ 1784844797750542336
author Dysangco, Andrew T.
Pierce, Tamra M.
Bravata, Dawn M.
author_facet Dysangco, Andrew T.
Pierce, Tamra M.
Bravata, Dawn M.
author_sort Dysangco, Andrew T.
collection PubMed
description We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2 cases). Among outpatient antibiotics, metronidazole had the highest rate (0.071 per 1,000 pills dispensed; n = 3 cases).
format Online
Article
Text
id pubmed-9726489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-97264892022-12-07 Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action Dysangco, Andrew T. Pierce, Tamra M. Bravata, Dawn M. Antimicrob Steward Healthc Epidemiol Concise Communication We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2 cases). Among outpatient antibiotics, metronidazole had the highest rate (0.071 per 1,000 pills dispensed; n = 3 cases). Cambridge University Press 2022-08-26 /pmc/articles/PMC9726489/ /pubmed/36483417 http://dx.doi.org/10.1017/ash.2022.286 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Concise Communication
Dysangco, Andrew T.
Pierce, Tamra M.
Bravata, Dawn M.
Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title_full Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title_fullStr Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title_full_unstemmed Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title_short Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
title_sort risk of antibiotics associated with clostridioides difficile infection: antibiotic stewardship in action
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726489/
https://www.ncbi.nlm.nih.gov/pubmed/36483417
http://dx.doi.org/10.1017/ash.2022.286
work_keys_str_mv AT dysangcoandrewt riskofantibioticsassociatedwithclostridioidesdifficileinfectionantibioticstewardshipinaction
AT piercetamram riskofantibioticsassociatedwithclostridioidesdifficileinfectionantibioticstewardshipinaction
AT bravatadawnm riskofantibioticsassociatedwithclostridioidesdifficileinfectionantibioticstewardshipinaction

Ejemplares similares